Immunomodulatory effects of Interleukin 2 in the circulation of melanoma patients and the added impact of VEGF inhibition with Ziv-aflibercept

被引：0
|
作者：
Khunger, Arjun [1 ]
Sarikonda, Ghanashyam [2 ]
Frankel, Paul [3 ]
Tsau, Jenn [2 ]
Alfonso, Zeni [2 ]
Gao, Jane [2 ]
Pahuja, Anil [2 ]
Vaupel, Christine [2 ]
Dakappagari, Naveen [2 ]
Tangri, Shabnam [2 ]
Tarhini, Ahmad [4 ,5 ]
机构：
[1] Mem Hosp West, Pembroke Pines, FL USA
[2] Navigate BioPharma Serv Inc, Carlsbad, CA USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Winship Comprehens Canc Ctr, Atlanta, GA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma
    Kathleen M. Beusterien
    Stacey J. Ackerman
    Kathryn Plante
    John Glaspy
    Peter Naredi
    Diana Wood
    Kurt Gehlsen
    Sanjiv S. Agarwala
    Supportive Care in Cancer, 2003, 11 : 304 - 312
  • [22] The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma
    Beusterien, KM
    Ackerman, SJ
    Plante, K
    Glaspy, J
    Naredi, P
    Wood, D
    Gehlsen, K
    Agarwala, SS
    SUPPORTIVE CARE IN CANCER, 2003, 11 (05) : 304 - 312
  • [23] CLINICAL PHASE-I EXPERIMENTATION WITH RECOMBINANT INTERLEUKIN-2 (BIOGEN) IN MELANOMA PATIENTS - INVIVO IMMUNOLOGICAL EFFECTS
    GAMBACORTIPASSERINI, C
    MAROLDA, R
    RADRIZZANI, M
    GALAZKA, AR
    BELLI, F
    FOSSATI, G
    CASCINELLI, N
    PARMIANI, G
    TUMORI, 1986, 72 (06) : 710 - 710
  • [24] BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS
    LOPEZ, M
    CARPANO, S
    CAVALIERE, R
    DILAURO, L
    AMEGLIO, F
    VITELLI, G
    FRASCA, AM
    VICI, P
    PIGNATTI, F
    ROSSELLI, M
    RASI, G
    GARACI, E
    ANNALS OF ONCOLOGY, 1994, 5 (08) : 741 - 746
  • [25] Effects of Allium sativum Stem Extract on Growth and Migration in Melanoma Cells through Inhibition of VEGF, MMP-2, and MMP-9 Genes Expression
    Gam, Da-Hye
    Park, Jae-Hyun
    Kim, Jun-Hee
    Beak, Dong-Ho
    Kim, Jin-Woo
    MOLECULES, 2022, 27 (01):
  • [26] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Ajjai Alva
    Gregory A. Daniels
    Michael K. K. Wong
    Howard L. Kaufman
    Michael A. Morse
    David F. McDermott
    Joseph I. Clark
    Sanjiv S. Agarwala
    Gerald Miletello
    Theodore F. Logan
    Ralph J. Hauke
    Brendan Curti
    John M. Kirkwood
    Rene Gonzalez
    Asim Amin
    Mayer Fishman
    Neeraj Agarwal
    James N. Lowder
    Hong Hua
    Sandra Aung
    Janice P. Dutcher
    Cancer Immunology, Immunotherapy, 2016, 65 : 1533 - 1544
  • [27] Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer
    van der Vliet, Hans J. J.
    Koon, Henry B.
    Yue, Simon C.
    Uzunparmak, Burak
    Seery, Virginia
    Gavin, Marc A.
    Rudensky, Alexander Y.
    Atkins, Michael B.
    Balk, Steven P.
    Exley, Mark A.
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2100 - 2108
  • [28] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Alva, Ajjai
    Daniels, Gregory A.
    Wong, Michael K. K.
    Kaufman, Howard L.
    Morse, Michael A.
    McDermott, David F.
    Clark, Joseph I.
    Agarwala, Sanjiv S.
    Miletello, Gerald
    Logan, Theodore F.
    Hauke, Ralph J.
    Curti, Brendan
    Kirkwood, John M.
    Gonzalez, Rene
    Amin, Asim
    Fishman, Mayer
    Agarwal, Neeraj
    Lowder, James N.
    Hua, Hong
    Aung, Sandra
    Dutcher, Janice P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (12) : 1533 - 1544
  • [29] Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial
    Garcia, Jorge A.
    Mekhail, Tarek
    Elson, Paul
    Triozzi, Pierre
    Nemec, Cheryl
    Dreicer, Robert
    Bukowski, Ronald M.
    Rini, Brian I.
    BJU INTERNATIONAL, 2011, 107 (04) : 562 - 570
  • [30] CLINICAL AND IMMUNE MODULATORY EFFECTS OF ALTERNATIVE WEEKLY INTERLEUKIN-2 AND INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA AND MELANOMA
    PICHERT, G
    JOST, LM
    FIERZ, W
    STAHEL, RA
    BRITISH JOURNAL OF CANCER, 1991, 63 (02) : 287 - 292
12345